Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: Human and murine models

Journal of Controlled Release

Volumn 164, Issue 1, 2012, Pages 17-25

  Marianecci, Carlotta ^a   Rinaldi, Federica ^a   Mastriota, Marica ^b   Pieretti, Stefano ^b   Trapasso, Elena ^c   Paolino, Donatella ^c   Carafa, Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Ammonium glycyrrhizinate; Inflammation; Niosomes; Skin tolerability; Toxicity

Indexed keywords

AMMONIUM GLYCYRRHIZINATE; ANTI-INFLAMMATORY ACTIVITY; CELLULOSE MEMBRANES; DELIVERY SYSTEMS; DRUG ENTRAPMENT; HUMAN MODEL; IN-VITRO; INFLAMMATION; LIQUORICE EXTRACTS; MURINE MODEL; NATURAL PRODUCTS; NIOSOMES; POTENTIAL APPLICATIONS; RELEASE PROFILES; SKIN ERYTHEMA;

PATHOLOGY; TOXICITY;

AMMONIUM COMPOUNDS;

AMMONIUM GLYCYRRHIZATE; CELLULOSE; CHOLESTEROL; NATURAL PRODUCT; NIOSOME; POLYSORBATE 85; SORBITAN LAURATE; SURFACTANT; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANISOTROPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG TOLERABILITY; ENCAPSULATION; ERYTHEMA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; ZETA POTENTIAL;

ADMINISTRATION, CUTANEOUS; ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; EDEMA; ERYTHEMA; GLYCYRRHIZIC ACID; HUMANS; KERATINOCYTES; LIPOSOMES; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; PAIN MEASUREMENT; SKIN; SKIN ABSORPTION;

EID: 84867750386     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.09.018     Document Type: Article

References (42)

1. A.D. Kinghorn, L. Pan, J.N. Fletcher, and H. Chai The Relevance of higher plants in lead compound discovery programs J. Nat. Prod. 74 2011 1539 1555
2. G.A. Statti, R. Tundis, G. Sacchetti, M. Muzzoli, A. Bianchi, and F. Menichini Variability in the content of active constituents and biological activity of Glycyrrhiza glabra Fitoterapia 75 2004 371 374
3. Y. Fu, T.C. Hsieh, J. Guo, J. Kunicki, M.Y. Lee, Z. Darzynkiewicz, and J.M. Wu Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells Biochem. Biophys. Res. Commun. 322 2004 263 270
4. G. Ignesti, L. Maleci, A. Medica, and R. Pirisino Piante Medicinali Botanica-Chimica-Farmacologia Tossicologia 1999 Pitagora Editrice Bologna, Italy
5. M.F. Chen, F. Shimada, H. Kato, S. Yano, and M. Kanaoka Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone Endocrinol. Jpn. 38 1991 167 174
6. A. Herold, L. Cremer, A. Calugaru, V. Tamas, F. Ionescu, S. Manea, and G. Szegli Hydroalcoholic plant extracts with antiinflammatory activity Roum. Arch. Microbiol. Immunol. 62 2003 117 129
7. T. Fukai, K. Satoh, T. Nomura, and H. Sakagami Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra Fitoterapia 74 2003 624 629
8. K. Morteza-Semnani, M. Saeedi, and B. Shahnavaz Comparison of antioxidant activity of extract from roots of licorice(Glycyrrhiza glabra L.) to commercial antioxidants in 2% hydroquinone cream J. Cosmet. Sci. 54 2003 551 558
9. D. Paolino, G. Lucania, D. Mardente, F. Alhaique, and M. Fresta Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers J. Control. Release 106 2005 99 110
10. S. Matsui, H. Matsumoto, Y. Sonoda, K. Ando, E. Aizu-Yokota, T. Sato, and T. Kasahara Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line Int. Immunopharmacol. 4 2004 1633 1644
11. T. Genovese, M. Menegazzi, E. Mazzon, C. Crisafulli, R. Di Paola, M. Dal Bosco, Z. Zou, H. Suzuki, and S. Cuzzocrea Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice Shock 31 2009 367 375
12. M. Carafa, C. Marianecci, G. Lucania, E. Marchei, and E. Santucci New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity J. Control. Release 95 2004 67 74
13. M. Carafa, C. Marianecci, F. Rinaldi, E. Santucci, S. Tampucci, and D. Monti Span® and Tween® neutral and pH-sensitive vesicles: characterization and in vitro skin permeation J. Liposome Res. 19 2009 332 340
14. R.M. Handjani-Vila, A. Ribier, and G. Vanlerberghe G. Gregoriadis, 2nd ed. Nonionic Surfactant Vesicles, in Liposome Technology vol. II 1993 CRC Press Boca Raton, FL 201 213
15. I.F. Uchegbu, and A.T. Florence Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry Adv. Colloid Interface Sci. 58 1995 1 55
16. A.J. Baille, A.T. Florence, L.I. Hume, G.T. Muirhead, and A. Rogerson The preparation and properties of niosomes-non-ionic surfactant vesicles J. Pharm. Pharmacol. 37 1985 863 868
17. D.A. Van Hal, J.A. Bouwstra, A. Van Rensen, E. Jeremiasse, T. De Vringer, and H.E. Junginger Preparation and characterization of nonionic surfactant vesicles J. Colloids Interface Sci. 178 1996 263 273
18. A. Manosroi, P. Wongtrakul, J. Manosroi, H. Sakai, F. Sugawara, M. Yuasa, and M. Abe Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol Colloids Surf. B: Biointerfaces 30 2003 129 138
19. D. Paolino, R. Muzzalupo, A. Ricciardi, C. Celia, N. Picci, and M. Fresta In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery Biomed. Microdevices 9 2007 421 433
20. C. Terzano, L. Allegra, F. Alhaique, C. Marianecci, and M. Carafa Non-phospholipid vesicles for pulmonary glucocorticoid delivery Eur. J. Pharm. Biopharm. 59 2005 57 62
21. H.E.J. Hofland, R. Van der Geest, H.E. Bodde, H.E. Junginger, and J.A. Bouwstra Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro Pharm. Res. 11 1994 659 664
22. I.F. Uchegbu, and S.P. Vyas Non-ionic surfactant based vesicles (niosomes) in drug delivery Int. J. Pharm. 172 1998 33 70
23. C.F. Komives, E. Lilley, and A.J. Russell Biodegradation of pesticides in nonionic water-in-oil microemulsions of Tween 85: relationship between micelle structure and activity Biotechnol. Bioeng. 43 2004 946 959
24. D. F. H. Wallach, Hybrid paucilamellar lipid vesicles containing a phospholipid or glycolipid and a surfactant in the lipid bilayers for transport of materials into the skin. Patent WO9104013 (1991).
25. M.A. Carluccio, M. Massaro, C. Bonfrate, L. Siculella, M. Maffia, G. Nicolardi, A. Distante, C. Storelli, and R. DeCaterina Oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet Arterioscler Thromb. Vasc. Biol. 19 1999 220 228
26. C. Marianecci, D. Paolino, C. Celia, M. Fresta, M. Carafa, and F. Alhaique Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts J. Control. Release 147 2010 127 135
27. M. Carafa, L. Di Marzio, C. Marianecci, B. Cinque, G. Lucania, K. Kajiwara, M.G. Cifone, and E. Santucci Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction Eur. J. Pharm. Sci. 28 2006 385 393
28. M. Hossann, M. Wiggenhorn, A. Schwerdt, K. Wachholz, N. Teichert, H. Eibl, R.D. Issels, and L.H. Lindner In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes Biochim. Biophys. Acta 1768 2007 2491 2499
29. A.M. Kligman, and E. Christophers Preparation of isolated sheets of human skin Arch. Dermatol. 88 1963 702 705
30. M. Colucci, F. Maione, M.C. Bonito, A. Piscopo, A. Di Giannuario, and S. Pieretti New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation Pharmacol. Res. 57 2008 419 425
31. S. Pieretti, A. Di Giannuario, M. De Felice, M. Perretti, and G. Cirino Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides Pain 109 2004 52 63
32. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19
33. A. Manconi, A.O. Vila, C. Sinico, J. Figueruelo, F. Molina, and A.M. Fadda Theoretical and experimental evaluation of decypolyglucoside vesicles as potential drug delivery systems J. Drug Deliv. Sci. Technol. 16 2006 141 146
34. L. Di Marzio, C. Marianecci, M. Petrone, F. Rinaldi, and M. Carafa Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20 Colloids Surf. B Biointerfaces 82 2011 18 24
35. L. Di Marzio, C. Marianecci, B. Cinque, M. Nazzarri, A.C. Cimini, L. Cristiano, M.G. Cifone, F. Alhaique, and M. Carafa pH-sensitive non-phospholipid vesicle and macrophage-like cells: binding, uptake and endocytotic pathway BBA Biomembr. 1778 2008 2749 2756
36. Yan Wu, Wuli Yang, Changchun Wang, Jianhua Hu, and Shoukuan Fu Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate International J. Pharm. 295 2005 235 245
37. W. Schütze, and C.C. Müller-Goymann Phase transition of a liposomal dispersion into a micellar solution induced by drug-loading Pharm. Res. 15 1998 538 543
38. Y.P. Chen, Y. Lu, and J.M. Chen Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt Int. J. Pharm. 376 2009 153 160
39. C.Y. Wang, T.C. Kao, W.H. Lo, and G.C. Yen Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions J. Agric. Food Chem. 59 2011 7726 7733
40. T.C. Kao, M.H. Shyu, and G.C. Yen Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation J. Agric. Food Chem. 58 2010 8623 8629
41. J.R. Shi, L.G. Mao, R.A. Jiang, Y. Qian, H.F. Tang, and J.Q. Chen Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice Int. Immunopharmacol. 10 2010 1235 1241
42. S. Pieretti, L. Dominici, A. Di Giannuario, N. Cesari, and V. Dal Piaz Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors Life Sci. 79 2006 791 800